MK-3475-045
Laufzeit: 01.01.2014 - 31.12.2020
imported
Kurzfassung
A phase III randomized clinical trial of Pembrolizumab versus Paclitaxel or Vinflunine in subjects with recurrent or progressive metastatic urothelial cancer
Laufzeit: 01.01.2014 - 31.12.2020
A phase III randomized clinical trial of Pembrolizumab versus Paclitaxel or Vinflunine in subjects with recurrent or progressive metastatic urothelial cancer